Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1/2 1Phase 1 1

Status

Completed 37Terminated 10Unknown 7Recruiting 7Active not recruiting 7Withdrawn 4

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3

Conditions

Multiple Myeloma 77Lymphoma, Follicular 20Lymphoma, Large B-Cell, Diffuse 18Neoplasms, Plasma Cell 11Lymphoma, Mantle-Cell 8Lymphoma, B-Cell, Marginal Zone 8Recurrence 7Smoldering Multiple Myeloma 6Lymphoma, B-Cell 6Leukemia, Lymphocytic, Chronic, B-Cell 6Neoplasms 5Lymphoma 4Lymphoma, Non-Hodgkin 3Plasmacytoma 2Neuroblastoma 2Neoplasm, Residual 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Neurologic Manifestations 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Primary Effusion 1Lymphoma, AIDS-Related 1Leukemia, Plasma Cell 1Leukemia 1Histiocytosis, Langerhans-Cell 1

Interventions

Dexamethasone 18Cyclophosphamide 16fludarabine 11pomalidomide 9pembrolizumab 9carfilzomib 9daratumumab 7Rituximab 7Lenalidomide 7Calcium Dobesilate 7fludarabine phosphate 6Cisplatin 6Bortezomib 6Gemcitabine 5venetoclax 4elotuzumab 4isatuximab 3Vincristine 3Radiotherapy 3Prednisone 3Letrozole 3Etoposide 3Doxorubicin 3Cytarabine 3tisagenlecleucel 2selinexor 2ruxolitinib 2palbociclib 2ixazomib 2dexamethasone 21-phosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Active not recruiting × Recurrence × Lenalidomide × Clear all
NCT04712097 2026-05-05

Celestimo

Hoffmann-La Roche

Phase 3 Active not recruiting
478 enrolled
Lymphoid

Lymphoma, Follicular, Recurrence

NCT02343042 2026-05-04

STOMP

Karyopharm Therapeutics Inc

Phase 1/2 Active not recruiting
300 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT05888493 2026-04-17

LEDA

Novartis

Phase 3 Active not recruiting
109 enrolled
Lymphoid

Lymphoma, Follicular, Recurrence

NCT01562405 2026-01-14

Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Massachusetts General Hospital

Phase 1 Active not recruiting
33 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT02390869 2025-12-02

FIL_RENOIR12

Fondazione Italiana Linfomi - ETS

Phase 3 Active not recruiting
128 enrolled
Lymphoid

Lymphoma, Follicular, Recurrence

NCT03836014 2024-12-06

CONFIRM

Assistance Publique - Hôpitaux de Paris

Phase 3 Active not recruiting
436 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT03651128 2022-12-15

KarMMa-3

Celgene

Phase 3 Active not recruiting
381 enrolled
Plasma cell

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡